Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 10, 2025 08:56 ET | Source: Longevity Life Advisors

Longevity Life Advisors Launches CancerEDGE: A Program Offering Advanced Cancer Genomics and Precision Health Services

Indianapolis, March 10, 2025 (GLOBE NEWSWIRE) -- Longevity Life Advisors announces the launch of CancerEDGE, a first-of-its-kind program designed to provide genomic testing and precision health...
October 10, 2024 09:00 ET | Source: Amydis, Inc.

Amydis to Present First Ocular Tracer Designed to Detect Transthyretin Amyloidosis (ATTR) at AAOOP Conference

Amydis is developing a topical eye test to potentially transform early diagnosis of amyloidosis and enable more people to benefit from available drugs
November 14, 2023 07:00 ET | Source: Amydis, Inc.

Amydis Receives $3.4 million NIH Commercialization Readiness Pilot Grant Award to Map Heterogeneity of Alzheimer’s Diseases in Human Clinical Trial Using Novel Retinal Tracer

Amydis Receives $3.4 million NIH Grant Award to Map Heterogeneity of Alzheimer’s in Human Clinical Trial Using Novel Retinal Tracer
November 02, 2023 07:00 ET | Source: Amydis, Inc.

Amydis Launches Phase 2 Glaucoma Clinical Program Using Novel Retinal Tracer to Detect Amyloid Beta

Amydis announces Phase 2 clinical program for its novel retinal tracer, AMDX-2011P, to detect amyloid-beta in glaucoma patients.
October 02, 2023 10:45 ET | Source: Accarent Health

Accarent Health to Offer GRAIL’s Galleri®, a Multi-Cancer Early Detection Test to its Network and Members

Baltimore, MD, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Accarent Health announced today the availability of Galleri®, a multi-cancer early detection (MCED) screening test to its network of patients,...
September 22, 2022 07:00 ET | Source: Amydis, Inc.

Amydis Announces Enrollment of First Participants in PROBE, a Phase 1/2a Trial Evaluating a Novel Retinal Tracer in People with Amyotrophic Lateral Sclerosis or Parkinson’s Disease

SAN DIEGO, Sept. 22, 2022 (GLOBE NEWSWIRE) -- Amydis Inc., a privately held clinical-stage company pioneering a platform of diagnostic drug candidates targeting CNS biomarkers in the eye, today...
August 18, 2022 07:00 ET | Source: Amydis, Inc.

Amydis Receives NIH Grant Award to Develop a Novel TDP-43 Retinal Tracer in Patients with ALS and FTD

SAN DIEGO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Amydis Inc., a leading ocular tracer pharmaceutical company with a broad portfolio of diagnostic drug candidates targeting CNS biomarkers in the eye,...
April 04, 2022 07:00 ET | Source: Amydis, Inc.

Amydis Appoints Dr. Robert N. Weinreb as First Chair of Scientific Advisory Board

SAN DIEGO, April 04, 2022 (GLOBE NEWSWIRE) -- Amydis Inc., a healthcare company developing a new class of molecular retinal diagnostics and digital biomarkers to accelerate the early detection and...